MDLDSOCSSDUVDM-QHCPKHFHSA-N
C25H26F7N7O — CID 118362543
Data last refreshed: (MolForge compound catalog, from PubChem)
About MDLDSOCSSDUVDM-QHCPKHFHSA-N
MDLDSOCSSDUVDM-QHCPKHFHSA-N (PubChem CID 118362543) has the molecular formula C25H26F7N7O and a molecular weight of 573.52 g/mol. Its IUPAC name is (2S)-2-[2-fluoro-4-(5,5,5-trifluoropentyl)phenyl]-4-[1-(2-methylpropyl)pyrazol-3-yl]-5-(2H-tetrazol-5-yl)-2-(trifluoromethyl)-1,3-dihydropyridin-6-one.
Molecular Properties
| Compound Name | MDLDSOCSSDUVDM-QHCPKHFHSA-N |
|---|---|
| PubChem CID | 118362543 |
| Molecular Formula | C25H26F7N7O |
| Molecular Weight | 573.52 g/mol |
| Exact Mass | 573.21 |
| IUPAC Name | (2S)-2-[2-fluoro-4-(5,5,5-trifluoropentyl)phenyl]-4-[1-(2-methylpropyl)pyrazol-3-yl]-5-(2H-tetrazol-5-yl)-2-(trifluoromethyl)-1,3-dihydropyridin-6-one |
| SMILES | CC(C)Cn1ccc(C2=C(c3nn[nH]n3)C(=O)N[C@@](c3ccc(CCCCC(F)(F)F)cc3F)(C(F)(F)F)C2)n1 |
| InChI | InChI=1S/C25H26F7N7O/c1-14(2)13-39-10-8-19(36-39)16-12-23(25(30,31)32,33-22(40)20(16)21-34-37-38-35-21)17-7-6-15(11-18(17)26)5-3-4-9-24(27,28)29/h6-8,10-11,14H,3-5,9,12-13H2,1-2H3,(H,33,40)(H,34,35,37,38)/t23-/m0/s1 |
| InChIKey | MDLDSOCSSDUVDM-QHCPKHFHSA-N |
| XLogP | 5.35 |
| TPSA | 101.38 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 573.52 |
| LogP ≤ 5 | 5.35 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118362543 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.